Get the Stockscreener App
1.97
0.51%
-0.01
22nd Century Group, Inc. stock is traded at $1.97, with a volume of 193.25K.
It is down -0.51% in the last 24 hours and down -35.20% over the past month.
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
See More
Previous Close:
$1.98
Open:
$1.98
24h Volume:
193.25K
Relative Volume:
0.21
Market Cap:
$7.23M
Revenue:
$29.78M
Net Income/Loss:
$-39.94M
P/E Ratio:
-0.0318
EPS:
-61.9139
Net Cash Flow:
$-16.12M
1W Performance:
-15.81%
1M Performance:
-35.20%
6M Performance:
-37.46%
1Y Performance:
-97.25%
1-Day Range:
$1.94
$2.04
1-Week Range:
$1.94
$2.45
52-Week Range:
$0.432
$73.71
22nd Century Group, Inc. Stock (XXII) Company Profile
Name
22nd Century Group, Inc.
Sector
Industry
Phone
716-270-1523
Address
8560 Main Street, Williamsville, NY
Compare XXII with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
1.97 | 804.44K | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-22 | Initiated | Alliance Global Partners | Buy |
| Jun-15-22 | Initiated | Craig Hallum | Buy |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Jul-23-21 | Initiated | Cowen | Outperform |
| Oct-16-17 | Reiterated | Chardan Capital Markets | Buy |
| Aug-11-16 | Reiterated | Chardan Capital Markets | Buy |
View All
22nd Century Group, Inc. Stock (XXII) Latest News
22nd Century Group ships first Pinnacle VLNⓇ reduced nicotine cigarettes - Investing.com
22nd Century CEO & Chairman Larry Firestone Provides Technology and Regulatory Update Letter to Stockholders - The Manila Times
First FDA-Authorized Reduced Nicotine Cigarettes: 22nd Century Expands with Major Brand Partnerships - Stock Titan
22nd Century Group Inc. Reversal Rally May Surprise BearsProfit Target & Momentum Based Trading Ideas - beatles.ru
22nd Century to Participate in the Emerging Growth Conference on August 20, 2025 - The Manila Times
Is 22nd Century Group Inc. part of any ETF2025 Fundamental Recap & Expert-Curated Trade Recommendations - newsyoung.net
22nd Century Group Inc. Rebound Backed by Sentiment ShiftPortfolio Performance Report & Community Consensus Picks - metal.it
22nd Century targets profitability in first half 2026 while advancing branded VLN launches - MSN
Technical Heatmap Flags 22nd Century Group Inc. for WatchMarket Performance Report & Weekly Setup with High ROI Potential - kangso.co.kr
22nd Century Group Posts Q2 Results, Expands VLN Distribution - Tobacco Reporter
22nd Century Group still reports no very-low-nicotine product revenue - Winston-Salem Journal
22nd Century Group Sales Drop 49 Percent - AOL.com
22nd Century: Q2 Earnings Snapshot - Norwalk Hour
22nd Century Group Expands VLN® Product Line Amid Financial Challenges - TipRanks
22nd Century Group's Q2 2025 Earnings Call: Unpacking Contradictions in Breakeven Goals, Cash Position, and Revenue Projections - AInvest
22nd Century Sees Profitability in H1 2026 Amid Branded VLN Launches - AInvest
Transcript : 22nd Century Group, Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Earnings call transcript: 22nd Century Group Q2 2025 sees stock drop in premarket - Investing.com India
Trendlines Suggest 22nd Century Group Inc. May Bottom Out SoonEarnings Performance Report & Momentum Based Trading Signals - newsyoung.net
22nd Century Group Stock Plunges 11.61% on Revenue Drop - AInvest
22nd Century Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
22nd Century Group reports quarterly earnings release for second quarter 2025 - Investing.com India
22nd Century Group Reports Second Quarter 2025 Financial Results - GuruFocus
22nd Century Group, Inc. Expands VLN® Early Adoption with New Partner Brand Launches and Increased State Authorizations - Quiver Quantitative
22nd Century's Low-Nicotine Cigarettes Hit Major Milestone with 1,000-Store Retail Expansion - Stock Titan
22nd Century Group Inc expected to post a loss of $6.21 a shareEarnings Preview - TradingView
22nd Century Provides Corporate Update On Its VLN® MRTP Renewal Process – The First and Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less - ADVFN Brasil
22nd Century to Release Financials Aug. 14 - Tobacco Reporter
22nd Century Group to Announce Second Quarter 2025 Results on August 14, 2025 - 富途牛牛
22nd Century Group to Announce Second Quarter 2025 Results on Au - GuruFocus
Anti-Smoking Pioneer 22nd Century Group Earnings: What to Expect From Q2 2025 Results - Stock Titan
22nd Century Group Announces Reduced-Nicotine Cigarette Launch - Tobacco Reporter
22nd Century Announces First Shipments of Pinnacle VLN® Products - GuruFocus
First-Ever FDA-Approved 95% Reduced Nicotine Cigarettes Hit 1000 Major US Stores - Stock Titan
Is 22nd Century Group Inc. a good long term investmentMaximize portfolio value with expert tips - Jammu Links News
Is 22nd Century Group Inc. a growth stock or a value stockUnmatched profit potential - Jammu Links News
What institutional investors are buying 22nd Century Group Inc. stockBuild a portfolio that outperforms the market - Jammu Links News
What catalysts could drive 22nd Century Group Inc. stock higher in 2025Invest smarter with actionable stock recommendations - Jammu Links News
Why is 22nd Century Group Inc. stock attracting strong analyst attentionAccelerated wealth building - Jammu Links News
How volatile is 22nd Century Group Inc. stock compared to the marketRealize consistent double-digit growth - Jammu Links News
When is 22nd Century Group Inc. stock expected to show significant growthInvest smarter with comprehensive market analysis - Jammu Links News
Should I hold or sell 22nd Century Group Inc. stock in 2025Discover breakthrough trading strategies - Jammu Links News
What are 22nd Century Group Inc. company’s key revenue driversRealize consistent double-digit growth - Jammu Links News
How strong is 22nd Century Group Inc. company’s balance sheetBuild a diversified portfolio for maximum returns - Jammu Links News
How many analysts rate 22nd Century Group Inc. as a “Buy”Tremendous growth potential - Jammu Links News
What is the risk reward ratio of investing in 22nd Century Group Inc. stockIdentify undervalued stocks poised to rally - Jammu Links News
How does 22nd Century Group Inc. compare to its industry peersCapitalize on market shifts with expert advice - Jammu Links News
22nd Century Group, Inc. Stock (XXII) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):